Moderna releases new Covid-19 vaccine data, final trial start date

Saying it plans to launch what will likely be one of the largest clinical trials the drug industry has seen before in less than two weeks, Moderna Inc. revealed more evidence from an early-stage trial of its potential vaccine that indicated it could be successful.   Moderna (Nasdaq: MRNA) released the data from the first test of its Covid-19 vaccine after markets closed Tuesday, which included 42 of the 45 subjects originally enrolled in the NIH-led study (An additional 110 subjects were enrolled…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news